Budget Impact Analysis of Introducing Tofacitinib For The Treatment of Patients With Rheumatoid Arthritis In Hong Kong

Autor:	EW Chan, Ick Wong, Xue Li, Swathi Pathadka
Rok vydání:	2018
Předmět:	medicine.medical_specialty Tofacitinib business.industry Health Policy Rheumatoid arthritis Internal medicine Public Health Environmental and Occupational Health medicine Budget impact medicine.disease business
Zdroj:	Value in Health. 21:S80
ISSN:	1098-3015
DOI:	10.1016/j.jval.2018.07.599
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::1ab45915748f8adb2e75dcd327bacdca https://doi.org/10.1016/j.jval.2018.07.599 Zobrazit plný text záznamu Full Text from ScienceDirect